CHECKPOINT THERAPEUTICS Trademark

Trademark Overview

On Friday, February 16, 2018, a trademark application was filed for CHECKPOINT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CHECKPOINT THERAPEUTICS trademark a serial number of 87800976. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Checkpoint Therapeutics, Inc.. The CHECKPOINT THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, lung diseases and tumors; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Pharmaceutical products, namely, agents in the form of powders, capsules, and coatings for tablets for use in delivery of a wide range of pharmaceuticals
checkpoint therapeutics

General Information

Serial Number87800976
Word MarkCHECKPOINT THERAPEUTICS
Filing DateFriday, February 16, 2018
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6373293
Registration DateTuesday, June 1, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesMedical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, lung diseases and tumors; Pharmaceutical preparations for the prevention and treatment of cancer; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Pharmaceutical products, namely, agents in the form of powders, capsules, and coatings for tablets for use in delivery of a wide range of pharmaceuticals
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2018
Primary Code005
First Use Anywhere DateWednesday, October 4, 2017
First Use In Commerce DateWednesday, October 4, 2017

Trademark Owner History

Party NameCheckpoint Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCheckpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCheckpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Tuesday, July 24, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 20, 2018NEW APPLICATION ENTERED
Saturday, February 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 1, 2018ASSIGNED TO EXAMINER
Monday, June 4, 2018PRIORITY ACTION WRITTEN
Monday, June 4, 2018PRIORITY ACTION E-MAILED
Monday, June 4, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, July 24, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 15, 2019SOU EXTENSION 1 FILED
Monday, August 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 21, 2018ASSIGNED TO LIE
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 15, 2019SOU EXTENSION 1 GRANTED
Monday, August 19, 2019SOU EXTENSION 2 FILED
Monday, August 19, 2019SOU EXTENSION 2 GRANTED
Wednesday, March 18, 2020SOU EXTENSION 3 GRANTED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2019SOU TEAS EXTENSION RECEIVED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, March 18, 2020SOU EXTENSION 3 FILED
Friday, March 5, 2021TEAS STATEMENT OF USE RECEIVED
Monday, April 26, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2020SOU TEAS EXTENSION RECEIVED
Monday, October 19, 2020SOU EXTENSION 4 FILED
Monday, October 19, 2020SOU EXTENSION 4 GRANTED
Wednesday, October 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 5, 2021USE AMENDMENT FILED
Tuesday, March 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 24, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, October 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 27, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

therapeutics checkpoint pharmaceutical preparations products treatment cancer diseases medical namely capsules other